publications-banner

Information about pipeline products

PublicationView

Pexidartinib
Other/Multi
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
Lee JH, Chen TWW, Hsu CH, et al.
Invest New Drugs. 2020;38(1):99-110.
Edoxaban
Cardiovascular - AF
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): A randomised, open-label, phase 3b trial
Goette A, Merino JL, Ezekowitz MD, et al.
Lancet. 2016;388(10055):P1995-2003.
Edoxaban
Cardiovascular - VTE
Edoxaban for venous thromboembolism in patients with cancer: Results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
Raskob GE, van Es N, Segers A, et al.
Lancet Haematol. 2016;3(8):e379-e387.
Edoxaban
Cardiovascular - AF
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano RP, Ruff CT, Braunwald E, et al.
N Engl J Med. 2013;369:2093-2104.
Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  

footer